Register Login

Abiopharma

  • Home
  • About
  • Newsroom
  • Company List
  • Events
  • Automated Tools
  • Contact

News list

TPST attributes changed

  • Technical Exchange News
  • May 28, 2026, 02:19 UTC
  • 5
  • 0 comments

TPST attributes changed: Attr: Fin_status N -> D;

Comment Full text

SCKT attributes changed

  • Technical Exchange News
  • May 28, 2026, 02:18 UTC
  • 4
  • 0 comments

SCKT attributes changed: Attr: Fin_status N -> D;

Comment Full text

TRANSCODE THERAPEUTICS, INC. (RNAZ)

  • Technical Exchange News
  • May 28, 2026, 02:18 UTC
  • 5
  • 0 comments

NASDAQ traded attribute type Financial_Status was changed. Previous value: Normal. New value: Deficient.

Comment Full text

RNAZ attributes changed

  • Technical Exchange News
  • May 28, 2026, 02:18 UTC
  • 3
  • 0 comments

RNAZ attributes changed: Attr: Fin_status N -> D;

Comment Full text

ICON PLC (ICLR)

  • Technical Exchange News
  • May 28, 2026, 02:17 UTC
  • 3
  • 0 comments

NASDAQ traded attribute type Financial_Status was changed. Previous value: Normal. New value: Delinquent.

Comment Full text

ICLR attributes changed

  • Technical Exchange News
  • May 28, 2026, 02:17 UTC
  • 5
  • 0 comments

ICLR attributes changed: Attr: Fin_status N -> E;

Comment Full text

IBG attributes changed

  • Technical Exchange News
  • May 28, 2026, 02:17 UTC
  • 5
  • 0 comments

IBG attributes changed: Attr: Fin_status N -> E;

Comment Full text

EMPG attributes changed

  • Technical Exchange News
  • May 28, 2026, 02:17 UTC
  • 7
  • 0 comments

EMPG attributes changed: Attr: Fin_status N -> E;

Comment Full text

DKI attributes changed

  • Technical Exchange News
  • May 28, 2026, 02:17 UTC
  • 7
  • 0 comments

DKI attributes changed: Attr: Fin_status D -> N;

Comment Full text

TEMPEST THERAPEUTICS, INC. (TPST)

  • Technical Exchange News
  • May 28, 2026, 01:38 UTC
  • 5
  • 0 comments

NASDAQ symbol attribute type Financial_Status was changed. Previous value: Normal. New value: Deficient.

Comment Full text
  • Previous
  • 141
  • 142
  • 143
  • 144
  • 145
  • Next

Search

News categories

  • Technical Exchange News(14130)
  • Event(6229)
  • SEC News(359825)
  • FDA Approval(10304)
  • Company Report(721)
  • Business News(220265)
Market reaction

© Copyright Abiopharma. All Rights Reserved
Designed by Alexey Vershinin